Advarra Technology Used by Academic Institutions During COVID-19

Applied Clinical Trials

Advarra updated progress it has made with academic institutions in regard to the company’s technology use in academic institutions. The update includes the following:

  • Henry Ford Health System is implementing Advarra’s Forte EDC under an accelerated two-week timeline to fast track the activation of its COVID-19 trial.

  • Advarra’s eRegulatory management system, Forte eReg, is being used to ensure regulatory compliance and remote access to regulatory info, by academic institutions, including Karmanos Cancer Institute.

  • Advarra worked with Yale University to identify a streamlined approach to study activation, monitoring, and reporting for its COVID-19 studies leveraging Advarra’s OnCore Enterprise Research System and its Forte Insights analytics platform.

For more information, click here.